Open | - |
Close | - |
Volume / Avg. | 0 / 8.578M |
Day Range | - - - |
52 Wk Range | 3.455 - 14.550 |
Market Cap | $999.461M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 16.71% |
Days to Cover | 5.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by UBS on Friday, February 16, 2024. The analyst firm set a price target for 12.00 expecting PACB to rise to within 12 months (a possible 221.72% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $3.73 last updated March 27, 2024 at 7:42 PM EDT.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.